Duren's Health Mart Logo

Get Healthy!

Results for search "Vaccines".

Show All Health News Results

Health News Results - 441

The Biden administration announced on Wednesday that it will support a controversial proposal to waive patent protections for coronavirus vaccines, while the drug industry warned such a move would actually dampen the development of vaccines.

The United States had been a holdout at the World Trade Organization over the proposal, which could give drugmakers around the world a look at t...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • May 6, 2021
  • |
  • Full Page

In two real-world studies, Pfizer's COVID-19 vaccine appears to be standing up well against the challenges posed by more contagious coronavirus variants from Britain and South Africa.

The Pfizer mRNA vaccine showed about 90% documented effectiveness in protecting against infection with the British B.1.1.7 variant and 75% effectiveness against the South African B.1.351 variant, according t...

Two doses of the Pfizer-BioNTech COVID-19 vaccine provide a high level of protection for populations, a new study shows.

The findings from Israel — the first nation to report national data on the vaccine — show that two doses provide more than 95% protection for people 16 and older against COVID-19 infection, hospitalization and death.

The study period was from Jan. 24 to April ...

The United States could see a sharp decline in COVID-19 cases by the end of July, according to a new report from the U.S. Centers for Disease Control and Prevention.

Six research teams asked to project future COVID-19 trends have concluded that new infections will drastically drop in July and continue to fall through September, the researchers reported May 5 in the Morbidity and Morta...

As coronavirus vaccination rates start to slow in the United States, President Joe Biden on Tuesday set a new goal to deliver at least one shot to 70% of adult Americans by July 4 while he tries to convince the hesitant to get inoculated.

Some states are leaving more than half of their available doses unordered, so Biden also announced that his administration will now shift doses fro...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • May 5, 2021
  • |
  • Full Page

The U.S. Food and Drug Administration plans to expand emergency use of Pfizer's coronavirus vaccine by next week so that children as young as 12 can be immunized.

After Pfizer's trial in adolescents showed its vaccine worked as well in teens as it does in adults, the FDA started preparing to add an amendment covering that age group to the vaccine's emergency use authorization, T...

More than 147 million Americans have gotten at least one dose of a COVID-19 vaccine, and they all have the same question:

What do I do with this immunization card they just handed me?

Whatever you do, don't throw it out, experts say.

An electronic record of your vaccination should be filed with your state by whoever gave you the jab, but holding on to your own paper record wil...

TUESDAY, May 4, 2021 (HealthDay News) -- Two widely used COVID-19 vaccines — Pfizer and Moderna — will likely remain powerfully protective against developing serious illness even if coronavirus variants somehow manage to infect vaccinated patients, new research suggests.

Both vaccines are based on messenger RNA (mRNA) technology. And investigators say that, at least...

Here's reassuring news for moms-to-be: Pregnant women who receive the Pfizer-BioNTech or Moderna COVID-19 vaccines appear to transfer protective antibodies to their babies, a new study says.

The researchers assessed 122 pregnant women who received the vaccines. They also analyzed the cord blood of the women's babies at the time of birth.

The helpful antibodies were found in 99% of t...

Americans' anxiety and concerns about COVID-19 remain high a year into the pandemic, and mental health effects of the health crisis are on the rise, a new survey shows.

Hispanic (73%) and Black Americans (76%) are more anxious about COVID-19 than white people (59%), according to the American Psychiatric Association (APA) online survey of 1,000 U.S. adults. It was conducted March 26 to Apr...

While more than half of American adults have gotten at least one dose of a coronavirus vaccine, many scientists and public health experts now believe that herd immunity cannot be reached in the foreseeable future.

Instead, the virus will most likely become a manageable threat that will circulate in the United States for years to come, causing hospitalizations and deaths but in much s...

FRIDAY, April 30, 2021 (HealthDay News) -- Anxiety was the cause of 64 vaccine reactions, including fainting, in people who got the Johnson & Johnson single-dose COVID-19 vaccine in early April at sites in five states, a new study finds.

Researchers led by Anne Hause of the U.S. Centers for Disease Control and Prevention noted that "anxiety-related events, including syn...

In a sign that the coronavirus pandemic is beginning to ebb in America, a new analysis finds the seven-day average of new COVID-19 deaths in the United States has hit its lowest point since last October.

As of Wednesday, 684 new deaths had been reported, data from Johns Hopkins University showed. That's roughly an 80% drop since January, CNN reported. And the decline has bee...

The HPV vaccine isn't reaching enough young American men, researchers report.

The vaccine protects against reproductive warts as well as cancers caused by human papillomavirus (HPV), the most common sexually transmitted infection in the United States.

Many young women get the HPV vaccine to help protect them against cervical cancer, but numbers are much lower among young men, the M...

About 20% of Americans on kidney dialysis are reluctant to get a COVID-19 shot, according to a new study.

Kidney failure patients on dialysis are at increased risk for COVID-related complications that could lead to hospitalization and death, so it's important for them to be vaccinated, researchers said.

"Finding that 80% of patients on dialysis were willing to get a COVID-19 vaccine...

U.S. resistance to getting a COVID-19 vaccine is slowly diminishing, a new online survey finds, but it still exists and at especially rates in some blue-collar jobs.

For adults under age 65 who are hesitant, reluctance is mainly driven by concerns about safety, side effects and distrust in government, the poll found. It's also largely linked to people's line of work.

The bottom line...

Over 100 American colleges will require that students get coronavirus vaccines if they want to be on campus in the fall, a new survey shows.

More than 660,000 cases have been linked to universities since the start of the pandemic, with one-third of those reported since Jan. 1, The New York Times reported.

And COVID-19 outbreaks still plague some campuses, even as stude...

Only 13.5% of people will suffer systemic side effects after getting Pfizer's coronavirus vaccine, a new study finds.

These systemic symptoms include headache, fatigue and tenderness. Most side effects are mild and peak in the day after being vaccinated, and they only last for one to two days, according to the findings.

The analysis was done by researchers from King's College Londo...

WEDNESDAY, April 28, 2021 (HealthDay News) -- There's some sobering news for the millions of Americans who skipped their second coronavirus vaccine dose: Doing so could greatly reduce their odds of avoiding severe illness.

In a "real-world" study of 417 adults aged 65 or older who got either the Pfizer or Moderna two-dose vaccines, effectiveness in keeping folks out of ...

Dr. Anthony Fauci said Tuesday that countries around the globe have failed to help avert the "tragic" coronavirus outbreak that is now overwhelming India, and he singled out wealthy nations for not providing equitable access to vaccines and treatments.

"The only way that you're going to adequately respond to a global pandemic is by having a global response, and a global response mean...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • April 28, 2021
  • |
  • Full Page

Most young people do want to protect others from COVID-19, according to polls of 14- to 24-year-olds that suggest focusing on this message may be effective.

"Public health campaigns should leverage youths' desire to protect others and not be the cause of spread," said Dr. Kao-Ping Chua, an assistant professor of pediatrics at the University of Michigan in Ann Arbor.

Chua is senior ...

Fully vaccinated Americans can now go without masks when walking, jogging or biking outdoors, or when dining with small groups at outdoor restaurants, U.S. health officials announced Tuesday.

The latest guidance, from the U.S. Centers for Disease Control and Prevention, followed growing calls from infectious disease experts to drop mask mandates outside because breezes rapidly disperse ai...

As coronavirus cases surge around the world, the White House said Monday that the United States will share up to 60 million doses of the AstraZeneca coronavirus vaccine with other countries.

The announcement came as India's health system showed signs of collapse amid a soaring case count. The AstraZeneca vaccine will be shipped out once it clears federal safety reviews, The New Y...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • April 27, 2021
  • |
  • Full Page

An experimental COVID-19 vaccine could potentially provide universal protection against future COVID variants as well as other coronaviruses — maybe even the ones responsible for the common cold. And it's dirt cheap — less than $1 a dose, researchers say.

The vaccine targets a part of the COVID virus' spike protein that appears to be highly resistant to mutation and is common across n...

More than 5 million Americans have missed the second dose of their COVID-19 vaccine, new government data shows.

The trend seems to be growing. According to the latest data, the number of vaccine recipients who missed their second dose now stands at nearly 8%, more than double the rate seen among people who got inoculated during the first several weeks of the national vaccine campaign,

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • April 26, 2021
  • |
  • Full Page

The United States should resume administering the Johnson & Johnson COVID-19 vaccine, a key advisory panel for the Centers for Disease Control and Prevention voted on Friday.

The agency's Advisory Committee on Immunization Practices (ACIP) has determined that the benefits of the vaccine in preventing deaths and hospitalizations far outweigh the risks of rare blood clots, risks that are ma...

More than a week after pressing "pause" on the rollout of the Johnson & Johnson COVID-19 vaccine, experts convened by the U.S. Centers for Disease Control and Prevention are scheduled to meet again Friday with an eye toward a decision on moving forward with the shot.

According to CNN, the CDC's Advisory Committee on Immunization Practices (ACIP) will reconvene from 11 a.m. to 5 p...

Heather Gould, a wedding planner in Sonoma, Calif., always had some social anxiety.

Before the pandemic, she'd feel queasy and think twice about going out. But Gould would power through, talking her way through industry events and client meetings without tipping off her insecurities.

But now, after more than a year of interacting only with her closest friends and family, the challen...

Getting vaccinated may be everyone's best protection against COVID-19. But giving everyone fair access to vaccines will take more than just providing needles and vials, community health experts say.

Vaccines have not been reaching everyone equally, statistics show. Overall, Black and Hispanic people have been receiving smaller shares of vaccinations relative to their population and their ...

THURSDAY, April 22, 2021 (HeathDay News) -- April 16 was the first day that any Californian aged 16 or older became eligible to get the COVID-19 vaccine.

And at a bustling vaccination center in Pomona, Calif., 16-year-old Ashley Madera was in line to get her first dose of the Pfizer vaccine.

"I think that this vaccine is effective," said Madera, who lives in nearby Rancho Cucamonga...

As demand for COVID-19 vaccination in the United States shows signs of declining, President Joe Biden on Wednesday offered businesses new incentives to help more workers get their shots.

He asked -- but did not mandate -- that businesses give employees paid time off to get vaccinated, and even offered special tax credits to businesses employing under 500 people, to help cover any costs.

Outspoken pandemic denier Ted Nugent announced this week that he's tested positive for COVID-19, after 10 days of symptoms so severe that at times he "literally could hardly crawl out of bed."

But despite his illness, the Republican rocker from Michigan remains skeptical about COVID vaccines.

"I haven't taken the vaccine, because nobody knows what's in it," Nugent said in a Facebook...

Since the first COVID-19 vaccine was approved in December, millions of Americans have eagerly sought to find and receive one. But a new report finds that that could change over the next few weeks, as the pool of eager recipients shrinks and only the vaccine-hesitant remain.

"While timing may differ by state, we estimate that across the U.S. as a whole we will likely reach a tipping point...

Only certain people with high-risk allergy histories need to consult an allergist before they get a COVID-19 vaccine, according to new research.

Investigators have updated their prior guidelines after analyzing data from more than 65,000 people who were fully vaccinated.

"With more time and experience, we have been able to significantly narrow the group of patients with prior aller...

As of Monday, every American aged 16 or older in all 50 states is now open to receive the COVID-19 vaccine, meeting President Joe Biden's promise to deliver vaccines to all adults by April 19.

"If you're 16 or over, it is your turn to get vaccinated, no matter where you live," Andy Slavitt, White House senior adviser for COVID-19 response, said during a briefing Monday, CBS News ...

Half of all Americans aged 18 or older have now gotten at least one shot in the arm of a COVID-19 vaccine, the U.S. Centers for Disease Control and Prevention announced Sunday.

The agency said that almost 130 million people -- 50.4% of the U.S. adult population -- have received at least one dose of vaccine, while almost 84 million adults, or nearly a third (32.5%), are fully vaccinated.

Vaccinated Americans will probably need booster shots to guard against emerging coronavirus variants in the future, a White House adviser and Pfizer's CEO said Thursday.

The United States is already planning for future booster shots, Dr. David Kessler, chief science officer for the pandemic response, said during a House subcommittee hearing on the country's vaccination efforts.

<...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • April 16, 2021
  • |
  • Full Page

While U.S. federal government experts probe potential risks of the Johnson & Johnson vaccine, what do you need to know if you have had the one-dose COVID shot or hope to get it?

Experts at the American Heart Association (AHA) describe what to look out for.

The U.S. Centers for Disease Control and Prevention and the U.S. Food & Drug Administration paused administration of the J&J (J...

Young adults, take note: A new study finds that even if you have suffered a bout of COVID-19, it is not a guarantee against a second infection.

Researchers said the results show that even those young people who've been struck by the new coronavirus still need to be vaccinated against it.

The study was conducted between May and November 2020 and included more than 2,300 healthy U.S. ...

THURSDAY, April 15, 2021 (HealthDay News) -- Dermatologists liken skin to a window that can reveal what is going on inside the body, and a rash that sometimes follows a COVID-19 vaccine is one example.

When you get the shot, your immune system activates, preparing to recognize and fight off the virus in the future. This response and the inflammation that goes with it ca...

Many American teens and young adults are now embracing the chance to get COVID-19 vaccines, a new survey finds.

But youth-focused messaging will still be needed to convince a minority of those aged 14 to 24 that they should be vaccinated, the University of Michigan researchers said. Still, the good news is that more young people are ready to get their shots than said they were ready to do...

The fate of Johnson & Johnson's coronavirus vaccine hung in the balance on Thursday after a government advisory committee said it needed more time and evidence to determine whether unusual, but severe, blood clots seen in a handful of people were caused by the vaccine.

So far, only six clotting cases have been officially reported out of more than 7 million shots given of the one-dose...

The Biden Administration sought to reassure Americans on Tuesday that the pausing of Johnson & Johnson's coronavirus vaccine is science at work, and not evidence that COVID-19 vaccines are unsafe.

The pause was first issued Tuesday morning following reports that rare but serious blood clots had developed in six women after they took J&J's vaccine. The Advisory Committee on Immunizati...

Extremely rare but life-threatening blood clots linked to the Johnson & Johnson COVID-19 vaccine appear similar to those caused by the AstraZeneca vaccine approved for use in Europe and Canada, U.S. health officials said Tuesday.

Federal officials called for a "pause" in use of the one-dose J&J vaccine while they review data linked to six women between 18 and 48 years of age who developed...

If you've got questions about COVID-19 vaccines, you're not the only one. Even as many people rush to get their shots, surveys show others just aren't sure about them.

Dr. Won Lee, medical director of Boston Medical Center's Home Care Program, understands. "There's so much misinformation out there," she said. "And it's hard for anyone to know what to believe."

Lee is part of a medic...

After six people who received the Johnson & Johnson one-dose COVID-19 vaccine developed a type of rare and severe blood clot, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention on Tuesday each said they will seek a "pause" in use of the shots as they review the data.

The six cases involved what's known as a cerebral venous sinus thrombosis (CVST), a ...

Two new studies out of Britain find that although the now-dominant "U.K. variant" of the new coronavirus does spread more quickly, it does not appear to lead to more severe disease in those made ill.

The findings should help allay fears that more patients will die after infection with the variant, officially labeled B.1.1.7.

Scientists published the findings online April 12 in two<...

People living with someone who has COVID-19 appear to get powerful protection against infection when they are given Regeneron's antibody cocktail, a new study shows.

The findings suggest that beyond preventing the worst outcomes for coronavirus infection when given early enough, the cocktail could also prevent people from getting sick in the first place, the company said Monday.

<...

Once you've landed that coveted coronavirus vaccine appointment, you'll likely have to fill out a form on your medical history and whether you're allergic to any of the vaccine's ingredients. But there could be another question waiting for you: Have you ever had dermal filler injections?

That's because -- in rare cases -- people who've had the face-plumping injections can develop a mild, ...

People with cancers of the blood, bone marrow or lymph nodes are at an increased risk of not making protective coronavirus antibodies after COVID-19 vaccination, a new study warns.

The risk is particularly high for those with chronic lymphocytic leukemia (CLL). The researchers urged these patients and those who interact with them to get vaccinated but to keep wearing masks and practicing...

Show All Health News Results